These findings hint that, while vaccination under concurrent TNF inhibition induced similar amounts of antigen-specific T cells, HCs and TNFi-treated patients with IBD differed in IFN-γ– and IL-2–producing fractions. The gene discussed is IFNG; the disease is inflammatory bowel disease.